[1] Nie S P, Zhang H, Li W J, et al. Current development of polysaccharides from Ganoderma: Isolation, structure and bioactivities[J]. Bioactive Carbohydrates and Dietary Fibre, 2013, 1(1): 10-20.[2] Li W J, Chen Y, Nie S P, et al. Ganoderma atrum polysaccharide induces anti-tumor activity via the mitochondrial apoptotic pathway related to activation of host immune response[J]. J Cell Biochem, 2011, 112(3): 860-871.[3] Yu Q, Nie S P, Wang J Q, et al. Polysaccharide from Ganoderma atrum induces tumor necrosis factor-α secretion via phosphoinositide 3-kinase/Akt, mitogen-activated protein kinase and nuclear factor-κB signaling pathways in RAW264. 7 cells[J]. Int Immunopharmacol, 2012.[4] 余强, 聂少平, 李文娟, 等. 黑灵芝多糖对 D-半乳糖致衰老小鼠的作用研究[J]. 食品科学, 2009, 30(17): 305-307.[5] Li W J, Nie S P, Xie M Y, et al. Ganoderma atrum polysaccharide attenuates oxidative stress induced by D-galactose in mouse brain[J]. Life Sci, 2011, 88(15): 713-718.[6] Zhu K X, Nie S P, Li C, et al. A newly identified polysaccharide from Ganoderma atrum attenuates hyperglycemia and hyperlipidemia[J]. Int J Biol Macromol, 2013, 57: 142-150.[7] Chen Y, Xie M Y, Nie S P, et al. Purification, composition analysis and antioxidant activity of a polysaccharide from the fruiting bodies of Ganoderma atrum[J]. Food Chem, 2008, 107(1): 231-241.[8] Srinivasan K, Viswanad B, Asrat L, et al. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening[J]. Pharmacol Res, 2005, 52(4): 313-320.[9] Reed M J, Meszaros K, Entes L J, et al. A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat[J]. Metabolism: clinical and experimental, 2000, 49(11): 1390.[10] Li W J, Nie S P, Yu Q, et al. Immune modulation of polysaccharides from Ganoderma atrum on immunosuppressed mice[J]. Food Sci., 2009, 30: 297-299.[11] Folts J D, Stamler J, Loscalzo J. Intravenous nitroglycerin infusion inhibits cyclic blood flow responses caused by periodic platelet thrombus formation in stenosed canine coronary arteries[J]. Circulation, 1991, 83(6): 2122-2127.[12] Rogério F, Júnior H J, Vieira A S, et al. Bax and Bcl-2 expression and TUNEL labeling in lumbar enlargement of neonatal rats after sciatic axotomy and melatonin treatment[J]. Brain Res, 2006, 1112(1): 80-90.[13] Cahill Jr G F, Ashmore J, Renold A E, et al. Blood glucose and the liver[J]. Am J Med, 1959, 26(2): 264-282.[14] 贾国琴, 许永辉, 董荣乔. 肝源性糖尿病研究进展[J]. 临床荟萃, 2009, 24(13): 1193-1194.[15] Baig N A, Herrine S K, Rubin R. Liver disease and diabetes mellitus.[J]. Clin Lab Med, 2001, 21(1): 193.[16] 刘丽丽, 杨成. 中西医治疗糖尿病性肝损伤的研究进展[J]. 中医药临床杂志, 2011, 23(8): 741-743.[17] MELLITUS D. Diagnosis and classification of diabetes mellitus[J]. Diabetes Care, 2011, 27: S5-S10.[18] McQuaid S E, Hodson L, Neville M J, et al. Downregulation of adipose tissue fatty acid trafficking in obesity a driver for ectopic fat deposition?[J]. Diabetes, 2011, 60(1): 47-55.[19] Zhu K X, Nie S P, Li C, et al. Antidiabetic and Pancreas-Protective Effects of Zinc Threoninate Chelate in Diabetic Rats may be Associated with its Antioxidative Stress Ability[J]. Biol Trace Elem Res, 2013: 1-8.[20] 欧阳健明, 彭花. 植物多糖对细胞氧化损伤的保护和修复作用[J]. 暨南大学学报 (自然科学与医学版, 2012, 33(5).[21] Reddy J K, Rao M S. Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation[J]. Am J Physiol-Gastr L, 2006, 290(5): G852-G858.[22] 吴学平, 彭彦霄, 伍雪芳, 等. 凋亡相关蛋白Bcl-2及Bax在糖尿病大鼠下颌下腺内的表达[J]. 解剖学杂志, 2009, 32(2): 155-158. |